The experimental breast cancer drug Iniparib appears to shrink tumors, increase the time tumors take to progress, and prolongs survival in women with triple negative breast cancer.
Source: MyBreastCancerNetwork.com – Latest Breast Cancer News
The experimental breast cancer drug Iniparib appears to shrink tumors, increase the time tumors take to progress, and prolongs survival in women with triple negative breast cancer.
Source: MyBreastCancerNetwork.com – Latest Breast Cancer News